Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The revision label updated from v3.3.1 to v3.3.2; no visible changes to study content.
    Difference
    0.0%
    Check dated 2025-12-01T16:48:23.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Publications section wording updated to indicate PubMed publications are automatically filled from PubMed and may not be about the study; the revision tag was updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:27:49.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    A new publication reference about Satralizumab in Thyroid Eye Disease was added to Publications, and a government funding lapse notice along with an older PubMed citation were removed.
    Difference
    0.3%
    Check dated 2025-11-17T06:25:09.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Added study site names Centro Oftalmologico Dr. Charles S.A., Medizinische Universitat Wien, and Universitatsklinikum Munster. Removed the previous diacritic-heavy spellings Centro Oftalmológico Dr. Charles S.A., Medizinische Universität Wien, Universitätsklinikum Münster from the Locations section.
    Difference
    0.3%
    Check dated 2025-11-10T03:35:40.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added new Publications section with a PubMed-listed 2025 study design for satralizumab in thyroid eye disease; no deletions present. This expands the core content with up-to-date research references.
    Difference
    3%
    Check dated 2025-10-12T14:19:18.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Major update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-05T09:29:06.000Z thumbnail image

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.